Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Xeris Biopharma Holdings, Inc. | 261,420 | reported | 28 Aug 2025 | tx 18+463,686−89,272 |
| NEOPHARM INC | 80,000 | reported | 05 Dec 2006 | tx 6+136,100−100 |
| Larimar Therapeutics, Inc. | 55,150 | reported | 19 May 2026 | tx 5+114,750 |
| IDM PHARMA, INC. | 43,000 | reported | 03 Apr 2008 | tx 2+73,000 |
| HORIZON PHARMA, INC. | 0 | reported | 06 Oct 2023 | tx 202+2,898,517−2,408,773 |
| XERIS PHARMACEUTICALS INC | 0 | reported | 05 Oct 2021 | tx 7+42,456−62,106 |
| Strongbridge Biopharma plc | 0 | reported | 05 Oct 2021 | tx 9+160,000−260,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 19 May 2026 | GRANT_AWARD | Larimar Therapeutics, Inc. | 55,150 | 0.00 USD | deriv |
| 27 Feb 2026 | PURCHASE | Larimar Therapeutics, Inc. | 5,000 | 5.00 USD | first after silence |
| 28 Aug 2025 | EXERCISE | Xeris Biopharma Holdings, Inc. | 47,040 | 6.66 USD | |
| 28 Aug 2025 | SALE | Xeris Biopharma Holdings, Inc. | 42,232 | 7.92 USD | |
| 28 Aug 2025 | EXERCISE | Xeris Biopharma Holdings, Inc. | 47,040 | 0.00 USD | deriv |
| 04 Jun 2025 | GRANT_AWARD | Xeris Biopharma Holdings, Inc. | 50,000 | 0.00 USD | |
| 13 May 2025 | GRANT_AWARD | Larimar Therapeutics, Inc. | 19,000 | 0.00 USD | deriv |
| 05 Jun 2024 | GRANT_AWARD | Xeris Biopharma Holdings, Inc. | 50,000 | 0.00 USD | |
| 29 May 2024 | GRANT_AWARD | Larimar Therapeutics, Inc. | 19,000 | 0.00 USD | deriv |
| 15 Mar 2024 | OTHER | Xeris Biopharma Holdings, Inc. | 6,502 | — | |
| 27 Nov 2023 | PURCHASE | Xeris Biopharma Holdings, Inc. | 5,400 | 1.87 USD | first after silence |
| 06 Oct 2023 | OTHER | HORIZON PHARMA, INC. | 45,352 | 116.50 USD | |
| 06 Oct 2023 | OTHER | HORIZON PHARMA, INC. | 80,944 | 116.50 USD | |
| 06 Oct 2023 | OTHER | HORIZON PHARMA, INC. | 105,808 | 116.50 USD | |
| 06 Oct 2023 | OTHER | HORIZON PHARMA, INC. | 2,655 | 116.50 USD | |
| 06 Oct 2023 | OTHER | HORIZON PHARMA, INC. | 3,809 | — | deriv |
| 06 Oct 2023 | OTHER | HORIZON PHARMA, INC. | 9,314 | — | deriv |
| 06 Oct 2023 | OTHER | HORIZON PHARMA, INC. | 164,469 | — | deriv |
| 06 Oct 2023 | OTHER | HORIZON PHARMA, INC. | 27,942 | — | deriv |
| 06 Oct 2023 | OTHER | HORIZON PHARMA, INC. | 4,654 | — | deriv |
| 06 Oct 2023 | OTHER | HORIZON PHARMA, INC. | 12,226 | — | deriv |
| 06 Oct 2023 | OTHER | HORIZON PHARMA, INC. | 19,044 | — | deriv |
| 06 Oct 2023 | OTHER | HORIZON PHARMA, INC. | 12,696 | — | deriv |
| 06 Oct 2023 | OTHER | HORIZON PHARMA, INC. | 11,426 | — | deriv |
| 06 Oct 2023 | OTHER | HORIZON PHARMA, INC. | 9,200 | — | deriv |
3 purchases reported after at least 12 months of silence — most recent on 27 Feb 2026.